Literature DB >> 11379880

Linkage of prostate cancer susceptibility loci to chromosome 1.

J Xu1, S L Zheng, B Chang, J R Smith, J D Carpten, O C Stine, S D Isaacs, K E Wiley, L Henning, C Ewing, P Bujnovszky, E R Bleeker, P C Walsh, J M Trent, D A Meyers, W B Isaacs.   

Abstract

Three prostate cancer susceptibility genes have been reported to be linked to different regions on chromosome 1: HPC1 at 1q24-25, PCAP at 1q42-43, and CAPB at 1p36. Replication studies analyzing each of these regions have yielded inconsistent results. To evaluate linkage across this chromosome systematically, we performed multipoint linkage analyses with 50 microsatellite markers spanning chromosome 1 in 159 hereditary prostate cancer families (HPC), including 79 families analyzed in the original report describing HPC1 linkage. The highest lod scores for the complete dataset of 159 families were observed at 1q24-25 at which the parametric lod score assuming heterogeneity (hlod) was 2.54 (P=0.0006) with an allele sharing lod of 2.34 (P=0.001) at marker D1S413, although only weak evidence was observed in the 80 families not previously analyzed for this region (hlod=0.44, P=0.14, and allele sharing lod=0.67, P=0.08). In the complete data set, the evidence for linkage across this region was very broad, with allele sharing lod scores greater than 0.5 extending approximately 100 cM from 1p13 to 1q32, possibly indicating the presence of multiple susceptibility genes. Elsewhere on chromosome 1, some evidence of linkage was observed at 1q42-43, with a peak allele sharing lod of 0.56 (P=0.11) and hlod of 0.24 (P=0.25) at D1S235. For analysis of the CAPB locus at 1p36, we focused on six HPC families in our collection with a history of primary brain cancer; four of these families had positive linkage results at 1p36, with a peak allele sharing lod of 0.61 (P=0.09) and hlod of 0.39 (P=0.16) at D1S407 in all six families. These results are consistent with the heterogeneous nature of hereditary prostate cancer, and the existence of multiple loci on chromosome 1 for this disease.

Entities:  

Mesh:

Year:  2001        PMID: 11379880     DOI: 10.1007/s004390100488

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  21 in total

1.  Genomewide linkage analysis of familial prostate cancer in the Japanese population.

Authors:  Hiroshi Matsui; Kazuhiro Suzuki; Nobuaki Ohtake; Seiji Nakata; Toshiyuki Takeuchi; Hidetoshi Yamanaka; Ituro Inoue
Journal:  J Hum Genet       Date:  2003-12-10       Impact factor: 3.172

2.  Exploring the within- and between-class correlation distributions for tumor classification.

Authors:  Xuelian Wei; Ker-Chau Li
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-25       Impact factor: 11.205

3.  An update analysis of two polymorphisms in encoding ribonuclease L gene and prostate cancer risk: involving 13,372 cases and 11,953 controls.

Authors:  Yuan-Yuan Mi; Li-Jie Zhu; Sheng Wu; Ning-Han Feng
Journal:  Genes Nutr       Date:  2011-04-17       Impact factor: 5.523

4.  Cancer Progress and Priorities: Prostate Cancer.

Authors:  Kevin H Kensler; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02       Impact factor: 4.254

Review 5.  Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.

Authors:  Timothy R Rebbeck
Journal:  Semin Radiat Oncol       Date:  2016-08-26       Impact factor: 5.934

Review 6.  Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood.

Authors:  Timothy R Rebbeck
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

Review 7.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

8.  SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.

Authors:  Christine Neslund-Dudas; Cathryn H Bock; Kristin Monaghan; Nora L Nock; James J Yang; Andrew Rundle; Deliang Tang; Benjamin A Rybicki
Journal:  Prostate       Date:  2007-11-01       Impact factor: 4.104

9.  Familial prostate cancer: the damage done and lessons learnt.

Authors:  Nassim Taherian; Nancy Hamel; Louis R Bégin; Tarek A Bismar; David E Goldgar; Bing-Jian Feng; William D Foulkes
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

Review 10.  Molecular basis for prostate cancer racial disparities.

Authors:  Santosh K Singh; James W Lillard; Rajesh Singh
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.